首页> 外文期刊>Investigative radiology >Multicenter comparison of high concentration contrast agent iomeprol-400 with iso-osmolar iodixanol-320: contrast enhancement and heart rate variation in coronary dual-source computed tomographic angiography.
【24h】

Multicenter comparison of high concentration contrast agent iomeprol-400 with iso-osmolar iodixanol-320: contrast enhancement and heart rate variation in coronary dual-source computed tomographic angiography.

机译:高浓度造影剂iomeprol-400与等渗碘克沙醇-320的多中心比较:冠状动脉双源计算机断层血管造影术中造影剂增强和心率变化。

获取原文
获取原文并翻译 | 示例
           

摘要

OBJECTIVES: To compare a contrast agent with high iodine concentration with an iso-osmolar contrast agent for coronary dual-source computed tomography angiography (DS-CTA), and to assess whether the contrast agent characteristics may affect the diagnostic quality of coronary DS-CTA. MATERIALS AND METHODS: Patients were randomized to receive either 80 mL of iodixa:nol-320 (Visipaque, GE Healthcare, Chalfont St. Giles, United Kingdom) or iomeprol-400 (Iomeron, Bracco Imaging SpA, Milan, Italy) at 5 mL/s. Mean, minimum, maximum heart rate, and its variation (max-min) were assessed during calcium scoring scan and coronary DS-CTA. Three off-site readers independently evaluated the image sets in terms of technical adequacy, reasons for inadequacy, vessel visualization, diagnostic confidence (based on a 5-point scale), and arterial contrast opacification in Hounsfield units (HUs). RESULTS: Ninety-six patients were included in the final evaluation. No significant differences were observed for pre- and postdose heart rate values for iomeron-400 compared with iodixanol-320, and changes in heart rate variation were also not significantly different (-2.3 +/- 11.7 vs. -2.5 +/- 7.3 bpm, P > 0.1). Contrast measurements in all analyzed vessels were significantly higher for iomeprol-400 (mean, 391.5-441.4 HU) compared with iodixanol-320 (mean, 332.3-365.5 HU, all P
机译:目的:将高碘浓度造影剂与等渗造影剂进行冠状动脉双源计算机断层血管造影(DS-CTA)的比较,并评估造影剂的特性是否会影响冠状动脉DS-CTA的诊断质量。材料与方法:将患者随机分为5 mL,分别接受80 mL的Iodixa:nol-320(Visipaque,GE Healthcare,Chalfont St. Giles,英国)或iomeprol-400(Iomeron,Bracco Imaging SpA,意大利米兰)。 / s。在钙评分扫描和冠状动脉DS-CTA中评估了平均,最小,最大心率及其变化(最大-最小)。三名异地读者在技术上的充分性,不足的原因,血管可视化,诊断置信度(基于5分制)和Hounsfield单位(HUs)的动脉造影混浊方面独立评估了图像集。结果:96例患者被纳入最终评估。与碘克沙醇-320相比,iomeron-400的给药前和给药后心率值均无显着差异,并且心率变化也无显着差异(-2.3 +/- 11.7 vs. -2.5 +/- 7.3 bpm ,P> 0.1)。与碘克沙醇-320(平均值,332.3-365.5 HU,所有P均= 0.0038)相比,所有分析血管中的iomeprol-400(平均值,391.5-441.4 HU)的对比度测量值均显着更高。冠状动脉的定性可视化(平均评分,碘美普尔为4.3-4.5,碘克沙醇为4.1-4.3,P = 0.15-0.28)或诊断置信度得分无显着差异。 HU与不透明段的数量成反比(所有读者P

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号